Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT ID: NCT03211351
Last Updated: 2018-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
95 participants
INTERVENTIONAL
2017-07-01
2018-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392
Dry Eye Treatment With Artificial Tears
NCT02420834
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liposic
Liposic was applied to one eye of patients in this group
Liposic
one eye of the participant recieved Lipoic
Tears Naturale Forte
Tears Naturale Forte was applied to one eye of patients in this group
Tears Naturale Forte
the other eye of the participant recieved Tears Naturale Forte
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liposic
one eye of the participant recieved Lipoic
Tears Naturale Forte
the other eye of the participant recieved Tears Naturale Forte
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The value of OSDI is over 12
* NBUT is less 5 seconds
* Schirmer 1 test is less 10mm
* The basical lipid layer grade is 1-2
Exclusion Criteria
* Known allergic sensitivity to any of the ingredients in Liposic or Tears Naturale Forte
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huaxia Eye Hospital Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chi Zhang, MD.PhD
Role: PRINCIPAL_INVESTIGATOR
Huaxia Eye Hospital of Foshan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huaxia Eye Hosptial of Foshan
Foshan, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FSHX-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.